Bruce Belanger
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 43
- Pancreatic and Hepatic Oncology Research 34
- Lung Cancer Research Studies 12
- Colorectal Cancer Treatments and Studies 11
- Cancer Treatment and Pharmacology 8
-
- Cancer therapeutics and mechanisms 12
- Co-authors
- Li‐Tzong Chen (18 shared papers)Jens T. Siveke (22 shared papers)Andrea Wang‐Gillam (21 shared papers)Floris A. de Jong (12 shared papers)Richard Hubner (20 shared papers)Daniel D. Von Hoff (16 shared papers)Beloo Mirakhur (8 shared papers)Teresa Macarulla (17 shared papers)
- Journals
- Annals of Oncology (14 papers)Journal of Clinical Oncology (13 papers)Journal of Hepatology (7 papers)European Journal of Cancer (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesTaiwanSpain
In The Last Decade
Bruce Belanger
52 papers receiving 851 citations
Peers
Comparison fields: 5 of 63
- Hepatology 242
- Oncology 467
- Epidemiology 377
- Cancer Research 109
- Biomaterials 73
Countries citing papers authored by Bruce Belanger
This map shows the geographic impact of Bruce Belanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Belanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Belanger more than expected).
Fields of papers citing papers by Bruce Belanger
This network shows the impact of papers produced by Bruce Belanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Belanger. The network helps show where Bruce Belanger may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce Belanger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 199 | |
| 2 | 2009 | 156 | |
| 3 | 2017 | 45 | |
| 4 | 2014 | 41 | |
| 5 | 2018 | 36 | |
| 6 | 2006 | 34 | |
| 7 | 2019 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2021 | 31 | |
| 10 | 2009 | 31 | |
| 11 | 2007 | 26 | |
| 12 | 2019 | 21 | |
| 13 | 2018 | 20 | |
| 14 | 2015 | 18 | |
| 15 | 2019 | 18 | |
| 16 | 2009 | 10 | |
| 17 | 2013 | 9 | |
| 18 | 2020 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2023 | 7 |
About Bruce Belanger
Bruce Belanger is a scholar working on Oncology, Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 59 papers that have together received 865 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (34 papers), Cancer therapeutics and mechanisms (12 papers), Lung Cancer Research Studies (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Neuroendocrine Tumor Research Advances (10 papers), Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Hepatology (242 citations), Oncology (467 citations), Epidemiology (377 citations), Cancer Research (109 citations) and Biomaterials (73 citations). Bruce Belanger has collaborated with scholars based in United States, Taiwan and Spain. Frequent co-authors include Li‐Tzong Chen, Jens T. Siveke, Andrea Wang‐Gillam, Floris A. de Jong, Richard Hubner, Daniel D. Von Hoff, Beloo Mirakhur, Teresa Macarulla, Jean‐Frédéric Blanc and Seng Gee Lim. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Hepatology, European Journal of Cancer and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.